Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

Evidence Brief: Coronary Computed Tomography Angiography with Fractional Flow Reserve in Noninvasive Diagnosis of Coronary Artery Disease

Click for list of published reports
Click for topic nomination form
Click for list of reports in progress

Subscribe to the
ESP Report RSS feed RSS feed icon
Evidence Brief: Coronary Computed Tomography Angiography with Fractional Flow Reserve in Noninvasive Diagnosis of Coronary Artery Disease

Prepared by:
Evidence Synthesis Program (ESP) Coordinating Center
Portland VA Health Care System
Portland, OR
Mark Helfand, MD, MPH, MS, Director

Recommended Citation:
Anderson J, Young S, Helfand M. Evidence Brief: Coronary Computed Tomography Angiography with Fractional Flow Reserve in Noninvasive Diagnosis of Coronary Artery Disease. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs. VA ESP Project #09-199; 2021.


Download PDF: Brief, Supplemental Materials

Takeaway

The impact of regularly utilizing HeartFlow for all patients referred for CCTA within the VA is likely low but use of HeartFlow in facilities that regularly utilize CCTA and in specific clinical scenarios could potentially reduce unnecessary use of invasive coronary angiography (ICA). Research in VA settings and comparing HeartFlow to specific noninvasive strategies is needed to determine the potential impact of HeartFlow within the VA.

Context

Coronary computed tomography angiography (CCTA) has good diagnostic accuracy for identifying obstructive coronary artery disease (CAD), but it cannot assess the functional significance of coronary artery narrowing. Fractional flow reserve (FFR) measured invasively is considered the gold standard for detecting functionally significant CAD. HeartFlow uses computer modeling to noninvasively estimate FFR from CCTA images. In 2019, the ESP synthesized the evidence on the use of HeartFlow for the diagnosis of CAD and identified important gaps in the evidence.

Findings

This updated synthesis included 24 studies on HeartFlow use in patients with suspected CAD. New evidence agreed with the previous finding that HeartFlow likely has good diagnostic accuracy for identifying obstructive CAD. No new evidence examined HeartFlow use in patients directly referred to ICA or as a substitute for other noninvasive testing. New evidence comparing ICA use in patients undergoing CCTA alone or HeartFlow had severe methodological limitations. New evidence agreed with the previous finding that short-term rates of cardiac events are similar in those receiving HeartFlow and those receiving other diagnostic strategies, but research on longer-term clinical outcomes is needed. CCTA use within the VA remains relatively low and is unlikely to change without direct evidence that a CCTA-based strategy is preferable to other noninvasive strategies. Controlled studies of ICA rates in patients with suspected coronary disease receiving CCTA or other noninvasive strategies and comparing HeartFlow to specific noninvasive strategies are needed.

See also

Evidence Brief: Coronary Computed Tomography Angiography with Fractional Flow Reserve in Non-invasive Diagnosis of Coronary Artery Disease (Management eBrief)


Questions about the HSR&D website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.